FCRIN - French Clinical Research Infrastructure Network

To mark World Stroke Day, the F-CRIN “StrokeLink” network is unveiling TIMELESS-TNT, a large-scale clinical trial set to begin in 2027. It will evaluate whether an injection of tenecteplase, a clot-busting drug, improves recovery in patients who have suffered a severe stroke and arrived at the hospital late, when administered before their transfer to a specialized unit. The clinical trial will include 592 patients across more than 50 centers, including about 40 non-university hospitals. It is sponsored by the Adolphe de Rothschild Foundation Hospital and coordinated by Dr. Pierre Seners, deputy chief of the neurovascular department and spokesperson for StrokeLink.

Unique in Europe, F-CRIN’s federated model brings together 29 complementary components: 27 accredited clinical research networks and platforms, a national coordination unit, and a platform providing support for the design and conduct of clinical trials. Discover an ecosystem designed to foster, support and accelerate clinical research projects.

To increase visibility and facilitate access to French clinical research for stakeholders around the world: this is the goal of “My French Clinical Trial,” a pioneering initiative launched by F-CRIN, French Healthcare, and a consortium of French clinical research organizations. The objectives of this portal for foreign industrial and academic sponsors are to better understand the French ecosystem and the processes for setting up clinical trials in France, and to quickly identify the right contacts (teams, research centers, etc.).